Public Release: 

Icahn School of Medicine at Mount Sinai to present findings at ACC

The Mount Sinai Hospital / Mount Sinai School of Medicine

Researchers from the Icahn School of Medicine at Mount Sinai will present their Late-Breaking Clinical Trial findings and other important research results advancing the field of cardiovascular medicine at the American College of Cardiology's (ACC) 65th Annual Scientific Session and Expo in Chicago, from April 2 to 4. Mount Sinai Heart is ranked No. 7 in the nation by U.S. News & World Report in its 2015 "Best Hospitals" issue.

The new findings advance our scientific knowledge of:

  • CABG alone or CABG and mitral valve repair as treatment strategies for moderate ischemic MR after two-years; and
  • the use of rate versus rhythm control in patients with atrial fibrillation.

Significant embargoed scientific presentations include:

Embargoed: Sunday, April 3, 12:30 p.m. CDT
Joint American College of Cardiology/New England Journal of Medicine Featured Clinical Research

Session 1-Session 406: Isch MR: Two-year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network

The study, which will be presented at ACC 2016 and published simultaneously online by the New England Journal of Medicine (NEJM), compares the two-year outcomes of treating patients with moderate ischemic MR with either coronary artery bypass grafting (CABG) alone or with both CABG and mitral valve repair. Annetine C. Gelijns, PhD, the Edmond A. Guggenheim Professor of Health Policy and Chair of the Department of Health Evidence and Policy at the Icahn School of Medicine at Mount Sinai, is the principal investigator for the Data Coordinating Center based at Mount Sinai for the NIH-sponsored Cardiothoracic Surgical Trials Network (CTSN), which conducted the clinical trial, and she is the corresponding author for the upcoming NEJM publication highlighting the results. The CTSN has eight core clinical centers, and Robert Michler, MD, Surgeon-in-Chief, Samuel I. Belkin Chair, Professor and Chairman, Department of Cardiothoracic and Vascular Surgery at Montefiore Health System, will present the research findings on behalf of the CTSN at ACC 2016.

Embargoed: Monday, April 4, 8:00 a.m.CDT
Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trial

Session 410: Rate v Rhythm: A Randomized Trial of Rate Control Versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery

The study, which will be presented at ACC 2016 and published simultaneously online by the NEJM, compares the strategies of rate versus rhythm control in patients with postoperative atrial fibrillation (POAF) after cardiac surgery to help inform management strategies to mitigate the risks of adverse outcomes caused by POAF. Annetine C. Gelijns, PhD, the Edmond A. Guggenheim Professor of Health Policy and Chair of the Department of Health Evidence and Policy at the Icahn School of Medicine at Mount Sinai, is the principal investigator for the Data Coordinating Center based at Mount Sinai for the NIH-sponsored Cardiothoracic Surgical Trials Network (CTSN), which conducted the clinical trial, and she is the corresponding author for the upcoming NEJM publication highlighting the results. The CTSN has eight core clinical centers, and Marc Gillinov, MD, Cardiothoracic Surgeon, Cleveland Clinic's Sydell and Arnold Miller Family Heart & Vascular Institute, will present the research findings on behalf of the CTSN at ACC 2016.

###

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services--from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is ranked as one of the nation's top 10 hospitals in Geriatrics, Cardiology/Heart Surgery, and Gastroenterology, and is in the top 25 in five other specialties in the 2015-2016 "Best Hospitals" issue of U.S. News & World Report. Mount Sinai's Kravis Children's Hospital also is ranked in seven out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology, while Mount Sinai Beth Israel is ranked regionally.

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.